Clinical Trials
2 trialsNCT01642004 2022-12-28
Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)
Bristol-Myers Squibb
Phase 3 Completed
NCT01721759 2022-06-28
Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens
Bristol-Myers Squibb
Phase 2 Completed